z-logo
open-access-imgOpen Access
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
Author(s) -
JyhMing Liou,
ChiehChang Chen,
ChungYu Chang,
MeiJyh Chen,
Y.-J. Fang,
Jung Yeon Lee,
ShihJer Hsu,
YaoChun Hsu,
Cheng-Hao Tseng,
PingHuei Tseng,
Lin Chang,
Wen Chang,
ChihHsien Wang,
ChiaTung Shun,
J.-Y. Wu,
YiChia Lee,
J.-T. Lin,
Ming–Shiang Wu
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks407
Subject(s) - levofloxacin , esomeprazole , clarithromycin , medicine , helicobacter pylori , amoxicillin , gastroenterology , metronidazole , agar dilution , drug resistance , intention to treat analysis , antibiotics , randomized controlled trial , microbiology and biotechnology , biology , minimum inhibitory concentration
The efficacy of sequential therapy and the applicability of genotypic resistance to guide the selection of antibiotics in the third-line treatment of Helicobacter pylori have not been reported. We aimed to assess the efficacy of genotypic resistance-guided sequential therapy in third-line treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom